Potential Interactions with Cardiovascular Medications Anyone taking prescription medications for cardiovascular conditions needs to carefully consider potential interactions with BPC-157
We recommend shorter sizes of 4-5mm and gauges of 30 and above
The small tetrapeptide size (~390 Da) makes Epithalon subject to rapid enzymatic cleavage and renal clearance
Moreover, GHK-Cu significantly inhibited the LPS-induced phosphorylation of p38 MAPK and slightly decreased the phosphorylation of JNK1/2, while having no observable effect on ERK1/2
Importantly, the FDA simultaneously announced its intention to consult the Pharmacy Compounding Advisory Committee (PCAC) at a scheduled hearing on July 23, 2026, regarding potentially adding BPC-157 (both acetate and free base forms) to the Category 1 approved list
Benoist CC, Kawas LH, Zhu M et al (2014) The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-Met system
